ATE353331T1 - Verfahren zur herstellung substituierter 5-amino- pyrazolo-(4,3-e)-1,2,4-triazolo(1,5-c)pyrimidin - Google Patents

Verfahren zur herstellung substituierter 5-amino- pyrazolo-(4,3-e)-1,2,4-triazolo(1,5-c)pyrimidin

Info

Publication number
ATE353331T1
ATE353331T1 AT04796445T AT04796445T ATE353331T1 AT E353331 T1 ATE353331 T1 AT E353331T1 AT 04796445 T AT04796445 T AT 04796445T AT 04796445 T AT04796445 T AT 04796445T AT E353331 T1 ATE353331 T1 AT E353331T1
Authority
AT
Austria
Prior art keywords
triazolo
pyrazolo
pyrimidine
amino
producing substituted
Prior art date
Application number
AT04796445T
Other languages
English (en)
Inventor
Shen-Chun Kuo
David Jieh-Shyh Tsai
Loc Thanh Tran
Pengyi Zhang
Andrew D Jones
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Application granted granted Critical
Publication of ATE353331T1 publication Critical patent/ATE353331T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
AT04796445T 2003-10-28 2004-10-26 Verfahren zur herstellung substituierter 5-amino- pyrazolo-(4,3-e)-1,2,4-triazolo(1,5-c)pyrimidin ATE353331T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US51505103P 2003-10-28 2003-10-28

Publications (1)

Publication Number Publication Date
ATE353331T1 true ATE353331T1 (de) 2007-02-15

Family

ID=34572798

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04796445T ATE353331T1 (de) 2003-10-28 2004-10-26 Verfahren zur herstellung substituierter 5-amino- pyrazolo-(4,3-e)-1,2,4-triazolo(1,5-c)pyrimidin

Country Status (18)

Country Link
US (4) US7223861B2 (de)
EP (1) EP1678182B1 (de)
JP (2) JP4782693B2 (de)
CN (2) CN101899050A (de)
AR (1) AR046560A1 (de)
AT (1) ATE353331T1 (de)
CA (1) CA2543431A1 (de)
CY (1) CY1106393T1 (de)
DE (1) DE602004004677T2 (de)
DK (1) DK1678182T3 (de)
ES (1) ES2278353T3 (de)
HR (1) HRP20070063T3 (de)
MX (1) MXPA06004722A (de)
PL (1) PL1678182T3 (de)
PT (1) PT1678182E (de)
SI (1) SI1678182T1 (de)
WO (1) WO2005044819A1 (de)
ZA (1) ZA200603307B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1283839E (pt) * 2000-05-26 2005-08-31 Schering Corp Antagonistas do receptor a2a da adenosina
DK1678182T3 (da) * 2003-10-28 2007-06-04 Schering Corp Fremgangsmåde til fremstilling af substituerede 5-amino-pyrazolo[4,3-E]-1,2,4-triazolo-[1,5-C]pyrimidiner
JPWO2006132275A1 (ja) * 2005-06-07 2009-01-08 協和醗酵工業株式会社 運動障害の予防および/または治療剤
EP2462144B1 (de) * 2009-08-07 2017-09-20 Merck Sharp & Dohme Corp. Verfahren zur herstellung eines 2-alkinyl substituierten 5-amino-pyrazolo-[4, 3-e]-1,2,4-triazolo [1,5-c] pyrimidins
US20110144049A1 (en) * 2009-10-21 2011-06-16 Serebruany Victor L Treating Cardiac Arrhythmias, Heart Failure, Peripheral Artery Disease and Stroke with Cyclopentyl-Triazolo-Pyrimidine or Derivative Thereof
WO2013024474A1 (en) * 2011-08-18 2013-02-21 Mapi Phrarma Ltd. Polymorphs of preladenant
US9529039B2 (en) 2012-05-10 2016-12-27 Unitechno, Inc. Semiconductor transporting and testing fixture
PL3197875T3 (pl) * 2014-09-26 2020-03-31 F. Hoffmann-La Roche Ag Sposoby wytwarzania związków (cyklopentylo[d]pirymidyn-4-ylo)piperazynowych
JP2022507734A (ja) 2018-11-20 2022-01-18 メルク・シャープ・アンド・ドーム・コーポレーション 置換アミノトリアゾロピリミジン及びアミノトリアゾロピラジンアデノシン受容体アンタゴニスト、医薬組成物及びそれらの使用
US12414952B2 (en) 2018-11-20 2025-09-16 Merck Sharp & Dohme Llc Substituted amino triazolopyrimidine and amino triazolopyrazine adenosine receptor antagonists, pharmaceutical compositions and their use
AR117164A1 (es) 2018-11-30 2021-07-14 Merck Sharp & Dohme Derivados de amino-triazoloquinazolina 9-sustituidos como antagonistas del receptor de adenosina, composiciones farmacéuticas y su uso para el tratamiento de diversos tipos de cáncer
JP2022511778A (ja) 2018-11-30 2022-02-01 メルク・シャープ・アンド・ドーム・コーポレーション アデノシン受容体拮抗薬としての7-、8-及び10-置換されたアミノトリアゾロキナゾリン誘導体、医薬組成物及びそれらの使用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4039733A1 (de) * 1990-12-13 1992-06-17 Basf Ag Substituierte 5-aminopyrazole
IT1264901B1 (it) * 1993-06-29 1996-10-17 Schering Plough S P A Analoghi eterociclici di 1,2,4-triazolo(15-c)pirimidine ad attivita' antagonista per il recettore a2 dell'adenosina
US6448253B1 (en) * 1998-09-16 2002-09-10 King Pharmaceuticals Research And Development, Inc. Adenosine A3 receptor modulators
PT1283839E (pt) 2000-05-26 2005-08-31 Schering Corp Antagonistas do receptor a2a da adenosina
WO2002062801A1 (en) * 2001-02-05 2002-08-15 Otsuka Pharmaceutical Factory, Inc. Triazoloquinazoline and pyrazolotriazolopyrimidine derivatives, medicinal compositions, adenosine a3 receptor affinity agents, ocular tension lowering agents, preparations for preventing and treating glaucoma and method of lowering ocular tension
CA2446099A1 (en) * 2001-05-01 2002-11-14 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds
AU2002346503A1 (en) * 2001-11-30 2003-06-17 Schering Corporation Adenosine A2a receptor antagonists
DK1678182T3 (da) * 2003-10-28 2007-06-04 Schering Corp Fremgangsmåde til fremstilling af substituerede 5-amino-pyrazolo[4,3-E]-1,2,4-triazolo-[1,5-C]pyrimidiner
ATE377599T1 (de) * 2003-12-01 2007-11-15 Schering Corp Verfahren zur herstellung von substituierten 5- aminopyrazolo(4,3-e)-1,2,4-triazolo(1,5- c)pyrimidinen

Also Published As

Publication number Publication date
US20050090492A1 (en) 2005-04-28
PL1678182T3 (pl) 2007-05-31
CA2543431A1 (en) 2005-05-19
JP2007509948A (ja) 2007-04-19
HRP20070063T3 (hr) 2007-04-30
AR046560A1 (es) 2005-12-14
PT1678182E (pt) 2007-04-30
WO2005044819A1 (en) 2005-05-19
US20090326241A1 (en) 2009-12-31
CN1898246B (zh) 2010-10-27
CN101899050A (zh) 2010-12-01
SI1678182T1 (sl) 2007-06-30
MXPA06004722A (es) 2006-07-05
ES2278353T3 (es) 2007-08-01
EP1678182B1 (de) 2007-02-07
DE602004004677T2 (de) 2007-11-15
US7439361B2 (en) 2008-10-21
US20090005559A1 (en) 2009-01-01
US7601833B2 (en) 2009-10-13
US7223861B2 (en) 2007-05-29
JP4782693B2 (ja) 2011-09-28
CN1898246A (zh) 2007-01-17
US20070203340A1 (en) 2007-08-30
ZA200603307B (en) 2008-07-30
EP1678182A1 (de) 2006-07-12
DK1678182T3 (da) 2007-06-04
HK1086008A1 (en) 2006-09-08
DE602004004677D1 (de) 2007-03-22
CY1106393T1 (el) 2011-10-12
JP2011116795A (ja) 2011-06-16

Similar Documents

Publication Publication Date Title
ATE498621T1 (de) Verfahren zur herstellung substituierter pyrimidine
ATE340819T1 (de) Verfahren zur herstellung von polyamiden
DE60324720D1 (de) Verfahren zur Herstellung dekorativer Gegenstände
DE602005026478D1 (de) Verfahren zur Herstellung von dünnwandigen Isogittergehäusen
DE60330050D1 (de) Verfahren zur herstellung von pyrimidinverbindungen
ATE397608T1 (de) Verfahren zur herstellung von anagrelid
DE50308650D1 (de) Verfahren zur herstellung von cellulosecarbamatformkörpern
EP1778419A4 (de) Verfahren zur herstellung von extrusionswerkzeugen
ATE376997T1 (de) Verfahren zur herstellung von 1,4- diphenylazetidinon-derivaten
DK1678182T3 (da) Fremgangsmåde til fremstilling af substituerede 5-amino-pyrazolo[4,3-E]-1,2,4-triazolo-[1,5-C]pyrimidiner
ATE377599T1 (de) Verfahren zur herstellung von substituierten 5- aminopyrazolo(4,3-e)-1,2,4-triazolo(1,5- c)pyrimidinen
ATE553103T1 (de) Verfahren zur herstellung von (s)-pantoprazol
DE502004004318D1 (de) Verfahren zur herstellung von metall-matrix-verbundwerkstoffen
ATE431339T1 (de) Verfahren zur herstellung von n-amino- substituierten heterocyclischen verbindungen
DE602004000126D1 (de) Verfahren zur Herstellung von selbststanzenden Muttern
ATE404506T1 (de) Verfahren zur herstellung poröser sinterformkörper
DE60333466D1 (de) Verfahren zur herstellung von aluminiumnitrid-sinterkörpern
DE50303611D1 (de) Verfahren zur herstellung von polyisobuten
ATE433965T1 (de) Verfahren zur herstellung von enantiomerenreinem mirtazapin
ATA332003A (de) Verfahren zur herstellung von metallschaumkörpern
ATE438631T1 (de) Verfahren zur herstellung von reinem melamin
DE502004007419D1 (de) Verfahren zur Herstellung von Radschüsseln
ATE402138T1 (de) Verfahren zur herstellung von 2- aminoindanderivaten
ATE349442T1 (de) Verbessertes verfahren zur herstellung von alpha- polymorphem eletriptan hydrobromid
ATE501282T1 (de) Verfahren zur herstellung von konzentraten

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1678182

Country of ref document: EP